What does Pralatrexate (Folotyn) do in plain English—and how does it work inside your body?
Pralatrexate is an FDA-regulated Folate Analog Metabolic Inhibitor (RxNorm RxCUI 1796419). Mechanistically, 12.1 Mechanism of Action Pralatrexate is a folate analog metabolic inhibitor that competitively inhibits dihydrofolate reductase. It is also a competitive inhibitor for polyglutamylation by the enzyme folylpolyglutamyl synthetase. This inhibition results in the depletion of thymidine and other biological molecules the synthesis of which depends on single carbon transfer. [1][2].
When your doctor writes a prescription for Pralatrexate (RxNorm RxCUI 1796419, also dispensed under brand names including Folotyn), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, 12.1 Mechanism of Action Pralatrexate is a folate analog metabolic inhibitor that competitively inhibits dihydrofolate reductase. It is also a competitive inhibitor for polyglutamylation by the enzyme folylpolyglutamyl synthetase. This inhibition results in the depletion of thymidine and other biological molecules the synthesis of which depends on single carbon transfer. [2].
Across real-world patient logs on dotMD (88% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Pralatrexate tablet bottle and confirm with your pharmacist that it matches your prescribed strength (40 mg/2mL Injection, 20 mg/mL Injection).